Company · CIK 0001680581 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Fulcrum Therapeutics, Inc. · FULC
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 16, 2026 PForm 4 → | Jul 20, 9:10 pm EDT | Kevin Tang +110% Owner | 167,616 | $3.55 | $594,675 | 7,080,945 | +2.42% | |
| Jul 13, 2026 PForm 4 → | Jul 15, 7:50 pm EDT | Kevin Tang +110% Owner | 249,946 | $3.57 | $891,067 | 6,913,329 | +3.75% | |
| Jun 26, 2026 SForm 4 → | Jun 30, 4:30 pm EDT | Alan EzekowitzDirector | 18,000 | $3.65 | $65,614 | 10,927 | −62.2% |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 AForm 4 → | Jul 2, 4:30 pm EDT | Sonja BanksDirector | 32,000 | — | — | 32,000 | — | |
| Jun 30, 2026 AForm 4 → | Jul 2, 4:30 pm EDT | Katina DortonDirector | 32,000 | — | — | 32,000 | — | |
| Jun 30, 2026 AForm 4 → | Jul 2, 4:30 pm EDT | Robert J GouldDirector | 32,000 | — | — | 32,000 | — | |
| Jun 30, 2026 AForm 4 → | Jul 2, 4:30 pm EDT | Kate HavilandDirector | 32,000 | — | — | 32,000 | — | |
| Jun 30, 2026 AForm 4 → | Jul 2, 4:30 pm EDT | Rachel K. KingDirector | 32,000 | — | — | 32,000 | — | |
| Jun 30, 2026 AForm 4 → | Jul 2, 4:30 pm EDT | James A GeraghtyDirector | 32,000 | — | — | 32,000 | — | |
| Jun 30, 2026 AForm 4 → | Jul 2, 4:30 pm EDT | Colin HillDirector | 32,000 | — | — | 32,000 | — | |
| Jun 30, 2026 AForm 4 → | Jul 2, 4:30 pm EDT | Alan EzekowitzDirector | 32,000 | — | — | 32,000 | — |